Cargando…

Testing the PRISMA-Equity 2012 Reporting Guideline: the Perspectives of Systematic Review Authors

Reporting guidelines can be used to encourage standardised and comprehensive reporting of health research. In light of the global commitment to health equity, we have previously developed and published a reporting guideline for equity-focused systematic reviews (PRISMA-E 2012). The objectives of thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Burford, Belinda J., Welch, Vivian, Waters, Elizabeth, Tugwell, Peter, Moher, David, O’Neill, Jennifer, Koehlmoos, Tracey, Petticrew, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794945/
https://www.ncbi.nlm.nih.gov/pubmed/24130684
http://dx.doi.org/10.1371/journal.pone.0075122
_version_ 1782287298372567040
author Burford, Belinda J.
Welch, Vivian
Waters, Elizabeth
Tugwell, Peter
Moher, David
O’Neill, Jennifer
Koehlmoos, Tracey
Petticrew, Mark
author_facet Burford, Belinda J.
Welch, Vivian
Waters, Elizabeth
Tugwell, Peter
Moher, David
O’Neill, Jennifer
Koehlmoos, Tracey
Petticrew, Mark
author_sort Burford, Belinda J.
collection PubMed
description Reporting guidelines can be used to encourage standardised and comprehensive reporting of health research. In light of the global commitment to health equity, we have previously developed and published a reporting guideline for equity-focused systematic reviews (PRISMA-E 2012). The objectives of this study were to explore the utility of the equity extension items included in PRISMA-E 2012 from a systematic review author perspective, including facilitators and barriers to its use. This will assist in designing dissemination and knowledge translation strategies. We conducted a survey of systematic review authors to expose them to the new items in PRISMA-E 2012, establish the extent to which they had historically addressed those items in their own reviews, and gather feedback on the usefulness of the new items. Data were analysed using Microsoft Excel 2008 and Stata (version 11.2 for Mac). Of 151 respondents completing the survey, 18.5% (95% CI: 12.7% to 25.7%) had not heard of the PRISMA statement before, although 83.4% (95% CI: 77.5% to 89.3%) indicated that they plan to use PRISMA-E 2012 in the future, depending on the focus of their review. Most (68.9%; 95% CI: 60.8% to 76.2%) thought that using PRISMA-E 2012 would lead them to conduct their reviews differently. Important facilitators to using PRISMA-E 2012 identified by respondents were journal endorsement and incorporation of the elements of the guideline into systematic review software. Barriers identified were lack of time, word limits and the availability of equity data in primary research. This study has been the first to ‘road-test’ the new PRISMA-E 2012 reporting guideline and the findings are encouraging. They confirm the acceptability and potential utility of the guideline to assist review authors in reporting on equity in their reviews. The uptake and impact of PRISMA-E 2012 over time on design, conduct and reporting of primary research and systematic reviews should continue to be examined.
format Online
Article
Text
id pubmed-3794945
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37949452013-10-15 Testing the PRISMA-Equity 2012 Reporting Guideline: the Perspectives of Systematic Review Authors Burford, Belinda J. Welch, Vivian Waters, Elizabeth Tugwell, Peter Moher, David O’Neill, Jennifer Koehlmoos, Tracey Petticrew, Mark PLoS One Research Article Reporting guidelines can be used to encourage standardised and comprehensive reporting of health research. In light of the global commitment to health equity, we have previously developed and published a reporting guideline for equity-focused systematic reviews (PRISMA-E 2012). The objectives of this study were to explore the utility of the equity extension items included in PRISMA-E 2012 from a systematic review author perspective, including facilitators and barriers to its use. This will assist in designing dissemination and knowledge translation strategies. We conducted a survey of systematic review authors to expose them to the new items in PRISMA-E 2012, establish the extent to which they had historically addressed those items in their own reviews, and gather feedback on the usefulness of the new items. Data were analysed using Microsoft Excel 2008 and Stata (version 11.2 for Mac). Of 151 respondents completing the survey, 18.5% (95% CI: 12.7% to 25.7%) had not heard of the PRISMA statement before, although 83.4% (95% CI: 77.5% to 89.3%) indicated that they plan to use PRISMA-E 2012 in the future, depending on the focus of their review. Most (68.9%; 95% CI: 60.8% to 76.2%) thought that using PRISMA-E 2012 would lead them to conduct their reviews differently. Important facilitators to using PRISMA-E 2012 identified by respondents were journal endorsement and incorporation of the elements of the guideline into systematic review software. Barriers identified were lack of time, word limits and the availability of equity data in primary research. This study has been the first to ‘road-test’ the new PRISMA-E 2012 reporting guideline and the findings are encouraging. They confirm the acceptability and potential utility of the guideline to assist review authors in reporting on equity in their reviews. The uptake and impact of PRISMA-E 2012 over time on design, conduct and reporting of primary research and systematic reviews should continue to be examined. Public Library of Science 2013-10-10 /pmc/articles/PMC3794945/ /pubmed/24130684 http://dx.doi.org/10.1371/journal.pone.0075122 Text en © 2013 Burford et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Burford, Belinda J.
Welch, Vivian
Waters, Elizabeth
Tugwell, Peter
Moher, David
O’Neill, Jennifer
Koehlmoos, Tracey
Petticrew, Mark
Testing the PRISMA-Equity 2012 Reporting Guideline: the Perspectives of Systematic Review Authors
title Testing the PRISMA-Equity 2012 Reporting Guideline: the Perspectives of Systematic Review Authors
title_full Testing the PRISMA-Equity 2012 Reporting Guideline: the Perspectives of Systematic Review Authors
title_fullStr Testing the PRISMA-Equity 2012 Reporting Guideline: the Perspectives of Systematic Review Authors
title_full_unstemmed Testing the PRISMA-Equity 2012 Reporting Guideline: the Perspectives of Systematic Review Authors
title_short Testing the PRISMA-Equity 2012 Reporting Guideline: the Perspectives of Systematic Review Authors
title_sort testing the prisma-equity 2012 reporting guideline: the perspectives of systematic review authors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794945/
https://www.ncbi.nlm.nih.gov/pubmed/24130684
http://dx.doi.org/10.1371/journal.pone.0075122
work_keys_str_mv AT burfordbelindaj testingtheprismaequity2012reportingguidelinetheperspectivesofsystematicreviewauthors
AT welchvivian testingtheprismaequity2012reportingguidelinetheperspectivesofsystematicreviewauthors
AT waterselizabeth testingtheprismaequity2012reportingguidelinetheperspectivesofsystematicreviewauthors
AT tugwellpeter testingtheprismaequity2012reportingguidelinetheperspectivesofsystematicreviewauthors
AT moherdavid testingtheprismaequity2012reportingguidelinetheperspectivesofsystematicreviewauthors
AT oneilljennifer testingtheprismaequity2012reportingguidelinetheperspectivesofsystematicreviewauthors
AT koehlmoostracey testingtheprismaequity2012reportingguidelinetheperspectivesofsystematicreviewauthors
AT petticrewmark testingtheprismaequity2012reportingguidelinetheperspectivesofsystematicreviewauthors